Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab a... | RTCL.TV
Channel: Social RTCL TV
Date: 24/07/2023

### Keywords ###
#adverseevent #atezolizumabplusbevacizumab #hepatocellularcarcinoma #lenvatinib #survival #RTCLTV #shorts

### Article Attribution ###
Title: Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma
Authors: Chung‐Wei Su, Wei Teng, Po‐Ting Lin, Wen‐Juei Jeng, Kuei‐An Chen, Yi‐Chung Hsieh, Wei‐Ting Chen, Ming‐Mo Ho, Chia‐Hsun Hsieh, Ching‐Ting Wang, Pei‐Mei Chai, Chen‐Chun Lin, Chun‐Yen Lin ,and Shi‐Ming Lin
Publisher: Wiley
DOI: 10.1002/cam4.5506
DOAJ URL: https://doaj.org/article/216f93a49f9b419c95928f65f96fe04e
Source URL: https://doi.org/10.1002/cam4.5506



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@socialrtcltv
Odysee Channel: https://odysee.com/@social_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:22 - Title 
0:00:28 - End